Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

The impact on healthcare, policy and practice from 36 multi-project research programmes: findings from two reviews.

Hanney S, Greenhalgh T, Blatch-Jones A, Glover M, Raftery J.

Health Res Policy Syst. 2017 Mar 28;15(1):26. doi: 10.1186/s12961-017-0191-y. Review.

2.

Research impact: a narrative review.

Greenhalgh T, Raftery J, Hanney S, Glover M.

BMC Med. 2016 May 23;14:78. doi: 10.1186/s12916-016-0620-8. Review.

3.

Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review.

Rao A, Brück K, Methven S, Evans R, Stel VS, Jager KJ, Hooft L, Ben-Shlomo Y, Caskey F.

PLoS One. 2016 May 11;11(5):e0155078. doi: 10.1371/journal.pone.0155078. eCollection 2016. Review.

4.

On variance estimate for covariate adjustment by propensity score analysis.

Zou B, Zou F, Shuster JJ, Tighe PJ, Koch GG, Zhou H.

Stat Med. 2016 Sep 10;35(20):3537-48. doi: 10.1002/sim.6943. Epub 2016 Mar 21.

PMID:
26999553
5.

Does health intervention research have real world policy and practice impacts: testing a new impact assessment tool.

Cohen G, Schroeder J, Newson R, King L, Rychetnik L, Milat AJ, Bauman AE, Redman S, Chapman S.

Health Res Policy Syst. 2015 Jan 1;13:3. doi: 10.1186/1478-4505-13-3.

6.

Four centuries on from Bacon: progress in building health research systems to improve health systems?

Hanney SR, González-Block MA.

Health Res Policy Syst. 2014 Sep 23;12:56. doi: 10.1186/1478-4505-12-56.

7.

Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes.

Glover M, Buxton M, Guthrie S, Hanney S, Pollitt A, Grant J.

BMC Med. 2014 Jun 16;12:99. doi: 10.1186/1741-7015-12-99.

8.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

9.

Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.

Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, Mhaskar R, Hozo I, Tu D, Stanton HA, Booth CM, Meyer RM.

PLoS One. 2013;8(3):e58711. doi: 10.1371/journal.pone.0058711. Epub 2013 Mar 21.

10.

Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT).

Ferris M, Norwood V, Radeva M, Gassman JJ, Al-Uzri A, Askenazi D, Matoo T, Pinsk M, Sharma A, Smoyer W, Stults J, Vyas S, Weiss R, Gipson D, Kaskel F, Friedman A, Moxey-Mims M, Trachtman H.

Clin Transl Sci. 2013 Feb;6(1):13-20. doi: 10.1111/cts.12003. Epub 2012 Oct 30.

11.

New treatments compared to established treatments in randomized trials.

Djulbegovic B, Kumar A, Glasziou PP, Perera R, Reljic T, Dent L, Raftery J, Johansen M, Di Tanna GL, Miladinovic B, Soares HP, Vist GE, Chalmers I.

Cochrane Database Syst Rev. 2012 Oct 17;10:MR000024. doi: 10.1002/14651858.MR000024.pub3.

12.

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project.

Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, Broderick J, Dromerick AW, Duncan P, Elkind MS, Johnston K, Kidwell CS, Meschia JF, Schwamm L; National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element Working Group.

Stroke. 2012 Apr;43(4):967-73. doi: 10.1161/STROKEAHA.111.634352. Epub 2012 Feb 2.

13.

Evaluation of health research: measuring costs and socioeconomic effects.

Roback K, Dalal K, Carlsson P.

Int J Prev Med. 2011 Oct;2(4):203-15.

14.

Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews.

Banzi R, Moja L, Pistotti V, Facchini A, Liberati A.

Health Res Policy Syst. 2011 Jun 24;9:26. doi: 10.1186/1478-4505-9-26.

15.

The institutional review board is an impediment to human research: the result is more animal-based research.

Rice MJ.

Philos Ethics Humanit Med. 2011 Jun 7;6:12. doi: 10.1186/1747-5341-6-12.

16.

NIH disease funding levels and burden of disease.

Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, Johnston SC.

PLoS One. 2011 Feb 24;6(2):e16837. doi: 10.1371/journal.pone.0016837.

17.

Enrollment of women and minorities in NINDS trials.

Burke JF, Brown DL, Lisabeth LD, Sanchez BN, Morgenstern LB.

Neurology. 2011 Jan 25;76(4):354-60. doi: 10.1212/WNL.0b013e3182088260. Epub 2011 Jan 5.

18.

Clinical judgement and the medical profession.

Kienle GS, Kiene H.

J Eval Clin Pract. 2011 Aug;17(4):621-7. doi: 10.1111/j.1365-2753.2010.01560.x. Epub 2010 Oct 25. Review.

19.

The economic case for new stroke thrombolytics.

Johnston SC.

Stroke. 2010 Oct;41(10 Suppl):S59-62. doi: 10.1161/STROKEAHA.110.597351. Review.

20.

Is informed consent related to success in exercise and diet intervention as evaluated at 12 months? DR's EXTRA study.

Länsimies-Antikainen H, Pietilä AM, Laitinen T, Kiviniemi V, Rauramaa R.

BMC Med Ethics. 2010 Jun 8;11:9. doi: 10.1186/1472-6939-11-9.

Supplemental Content

Support Center